Astera Labs, Inc. Common stock, shares authorized (in shares) remained flat by 0.0% to $1.00B in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $1.00B to $1.00B. Over 2 years (FY 2023 to FY 2025), Common stock, shares authorized (in shares) shows an upward trend with a 148.0% CAGR.
An increase indicates that shareholders have approved a higher ceiling for potential future equity issuance, often for capital raises or stock-based compensation.
This represents the maximum number of common shares that a corporation is legally permitted to issue under its articles...
Standard corporate governance metric; companies often maintain a buffer between authorized and outstanding shares.
other_common_stock_shares_authorized| Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $162.64M | $163.38M | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B | $1.00B |
| QoQ Change | — | +0.5% | +512.1% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | +514.9% | +512.1% | +0.0% | +0.0% | +0.0% | +0.0% |